Objective-A recent prospective study in patients with dilated cardiomyopathy has reported that the disease is familial in at least 20% of cases, but the pattern of inheritance could not be ascertained. 
Abstract
Objective-A recent prospective study in patients with dilated cardiomyopathy has reported that the disease is familial in at least 20% of cases, but the pattern of inheritance could not be ascertained. The presence of an autosomal dominant pattern, such as seen in hypertrophic cardiomyopathy, could make it possible to search for single gene defects with linkage analysis, whereas polygenic inheritance would be consistent with the autoimmune hypothesis. To assess the pattern of inheritance, we retrospectively identified patients with familial disease and assessed their first degree relatives (parents, siblings and children) for dilated cardiomyopathy.
Design and patients-The family history of 105 consecutive patients with dilated cardiomyopathy was reviewed and 14 who had at least one first degree relative with documented disease were identified as probands. Their healthy relatives (109) were studied by physical examination, electrocardiography, M mode and cross sectional echocardiography, and were classified as unequivocally normal or as potential carriers. The potential carriers had abnormal electrocardiography with either at least one echocardiographic measurement The occurrence of familial dilated cardiomyopathy has been previously underestimated. In a retrospective study 6% of the patients had familial disease.' In another study familial aggregation was found on the basis of history in 8-7% of patients who presented at a young age for cardiac transplantation. 2 Mestroni et al in a study of 165 consecutive patients, in which relatives were evaluated only if disease was suspected, reported that 7% of cases with dilated cardiomyopathy were familial.3 In a recent prospective study of patients whose first degree relatives (parents, siblings, children) were investigated regardless of whether they were suspected of having heart disease the frequency of familial dilated cardiomyopathy was 20%.
Pedigree analysis has produced families with patterns of inheritance consistent with both autosomal dominant,'-'3 and others with recessive.9 14 Also a large family with X linked inheritance has been described. ' 20 The medical records of all 105 patients with dilated cardiomyopathy were reviewed, also they were questioned to assess whether cases with presumed or confirmed heart disease were present in their families. Further information was obtained from attending physicians or from the hospitals in which the patients' relatives had been admitted. Patients with dilated cardiomyopathy who had at least one first degree relative with documented disease or positive necropsy result, were identified as familial cases (probands). In all probands the assessment included standard 12 lead electrocardiogram, M mode, cross sectional and Doppler echocardiography, 24 hour Holter monitoring, maximal treadmill exercise, right and left heart catheterisation, selective coronary arteriography, right and left ventriculography, and right ventricular endomyocardial biopsy.
RELATIVES
The study was approved by the local ethics committee and -participants gave informed written consent. All probands were asked whether they could invite their first degree relatives to enter the study. A three to four generation pedigree was created. If any first degree relative was found to have dilated cardiomyopathy, their first degree relatives were also contacted and included in the study. For deceased relatives, medical records were reviewed and the diagnosis of dilated cardiomyopathy was based on the same criteria used for the probands, as well as on the necropsy findings.
Patients' relatives with suspected myocardial disease underwent clinical, noninvasive, and where appropriate invasive evaluation. All participating relatives were screened with physical examination, standard 12 
Results

PROBANDS AND RELATIVES WITH DILATED CARDIOMYOPATHY
Fourteen of the 105 patients with dilated cardiomyopathy (13%) had at least one first degree relative with documented dilated cardiomyopathy and were identified as probands. There were 23 relatives of the 14 probands who had dilated cardiomyopathy, of whom 19 were dead (13 males, six females, age 43 (23), median 50) and four were alive. All 19 dead relatives had documented disease; in 12 the diagnosis was confirmed at necropsy, whereas in the remaining seven necropsy was not performed. Table 1 shows the baseline clinical and diagnostic features in the 14 probands and in the additional four living relatives with dilated cardiomyopathy (12 male, six female, age 50 (14)). We did not see two additional relatives with the diagnosis of dilated cardiomyopathy (data included in the pedigree are not shown). At the time of examination four patients (22%) were in New York Heart Association (NYHA) functional class I, four (22%) in class II, three in class III (17%), and seven in class IV (39%). They had severe left ventricular dilatation (mean percentage increase of the end diastolic dimension 46% Of the 124 apparently healthy relatives, 15 had systemic hypertension; they were assessed but were excluded from pedigree analysis. Of the remaining 109 relatives, 103 were symptom free, whereas six experienced effort dyspnoea. Twenty three of the 109 relatives (21%) were classified as potential carriers on the basis of an abnormal echocardiogram with or without abnormal electrocardiogram and were subdivided into two groups: subjects with abnormal echocardiogram only (n = 12) and subjects with both abnormal electrocardiogram and echocardiogram (n = 11). Tables 2 and 3 show the individual clinical and diagnostic features in the two groups. Of the 12 relatives who had only abnormal echocardiograms (10 males, two females, age 23 (9)) 10 patients (83%) were in NYHA functional class I, one (8%) in class II, and one in class III (8%). Overall they had a mild percentage increase of the left ventricular end diastolic dimension (12% (4%) from normal) but the mean value for percentage fractional shortening was within the normal range (30% (5%); however, three of these 12 relatives also had reduced percentage fractional shortening (< 26%).
Of the 11 subjects with both an abnormal electrocardiogram and echocardiogram (seven males, four females, age 38(15) seven reflect cutoffs in the definition of normality that are too sensitive. Indeed in most of the symptom free relatives the increase in the end diastolic dimension was only slight and it is possible that such minor abnormalities do not represent disease. The same applies to the electrocardiographic findings. Also the accuracy and interobserver variability of echocardiographic measurements, in particular when assessing mild abnormalities, have to be taken into account; thus, only follow up studies will clarify whether the relatives classified as potential carriers in this and in the prospective study by Michels et a14 will eventually develop dilated cardiomyopathy.
Our analysis included only patients with familial dilated cardiomyopathy who had no known causes of left ventricular dysfunction. Relatives were excluded if there was evidence of recognisable causes of myocardial dysfunction, such as hypertension, heavy alcohol intake, diabetes, or pregnancy. A previous work has shown familial aggregation of dilated cardiomyopathy with an autosomal dominant pattern of inheritance in patients who had heavy alcohol intake.10 These authors suggested that alcohol might be a factor modifying the course of the disease. Similarly there have been reports of familial peripartum dilated cardiomyopathy,29 and of families with the clinical phenotype of dilated cardiomyopathy and pathological findings of myocarditis, in which a defect in immunoregulation was suggested.30 These findings are provocative and warrant genetic investigation and family screening both in the idiopathic and secondary forms of dilated cardiomyopathy.
In our study, when the potential carriers were considered to be affected the pattern of inheritance was consistent with autosomal dominant with incomplete penetrance. If these carriers were classified as indeterminate or unaffected, however, there was apparent heterogeneity in the inheritance patterns (autosomal dominant in some families and autosomal recessive in others). This has been found in previous studies 1-3 9 and is most consistent with multiple genetic causes being responsible for disease transmission (polygenic inheritance).3' Again follow up evaluation of these carriers is needed to firmly establish the modality of inheritance in familial dilated cardiomyopathy. Single or multiple genetic defects could either directly cause the disease or predispose to the development of disease in the presence of environmental triggers. This is particularly interesting because recent evidence, which includes the presence of circulating cardiac autoantibodies,'7-'8 the finding of inappropriate expression on HLA molecules on endomyocardial biopsy tissue32 and the association with specific HLA-DR and possibly DQ phenotypes,33 supports the hypothesis that dilated cardiomyopathy is an organ specific autoimmune disease, at least in one third of non-familial cases. Dilated cardiomyopathy has analogies with another well recognised autoimmune disease, type I insulin dependent diabetes mellitus; in particular there is male predominance and association with the HLA-DR4 phenotype in both conditions. [33] [34] In type I diabetes mellitus there is polygenic inheritance that accounts for only 50% of disease susceptibility, the remainder being related to environmental causes. 34 In conclusion family screening of patients with dilated cardiomyopathy has the potential to give new insights into the aetiology, the pathogenesis, and the natural history of dilated cardiomyopathy. The absence of an obvious mode of inheritance in familial dilated cardiomyopathy is most consistent with this condition being not entirely genetic, with polygenic inheritance accounting only in part for disease susceptibility, the remainder being related to environmental factors such as seen in autoimmune conditions.
